{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:53:09Z","timestamp":1779929589615,"version":"3.53.1"},"reference-count":219,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03782-0","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T18:48:57Z","timestamp":1733165337000},"page":"2416-2436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The role of curcumin in modulating circular RNAs and long non-coding RNAs in cancer"],"prefix":"10.1007","volume":"27","author":[{"given":"Hamidreza","family":"Rismanchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohaddese","family":"Malek Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Mafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Khalilzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najma","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Khorramdelazad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnaz","family":"Mahmoodieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payman","family":"Rahimzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5953-3894","authenticated-orcid":false,"given":"Mina","family":"Alimohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooyan","family":"Makvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"3782_CR1","doi-asserted-by":"publisher","first-page":"9698258","DOI":"10.1155\/2018\/9698258","volume":"2018","author":"M Wojcik","year":"2018","unstructured":"Wojcik M, Krawczyk M, Wojcik P, Cypryk K, Wozniak LA. Molecular mechanisms underlying curcumin-mediated therapeutic effects in type 2 diabetes and cancer. Oxid Med Cell Longev. 2018;2018:9698258.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"3782_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/08982104.2022.2086567","volume":"33","author":"MA Obeid","year":"2023","unstructured":"Obeid MA, Alsaadi M, Aljabali AA. Recent updates in curcumin delivery. J Liposome Res. 2023;33(1):53\u201364.","journal-title":"J Liposome Res"},{"issue":"1","key":"3782_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/neu.2019.17","volume":"32","author":"BE Leonard","year":"2020","unstructured":"Leonard BE, Wegener G. Inflammation, insulin resistance and neuroprogression in depression. Acta Neuropsychiatr. 2020;32(1):1\u20139.","journal-title":"Acta Neuropsychiatr"},{"issue":"35","key":"3782_CR4","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.2174\/0929867330666230302114522","volume":"30","author":"S Lavian","year":"2023","unstructured":"Lavian S, Mardaneh P, Bagherniya M, Emami SA, Butler AE, Sahebkar A. The effect of synthetic curcumin analogues on obesity, diabetes and cardiovascular Disease: a literature review. Curr Med Chem. 2023;30(35):3979\u201392.","journal-title":"Curr Med Chem"},{"key":"3782_CR5","first-page":"1","volume":"2024","author":"T Abdul-Rahman","year":"2024","unstructured":"Abdul-Rahman T, Awuah WA, Mikhailova T, Kalmanovich J, Mehta A, Ng JC, et al. Antioxidant, anti-inflammatory and epigenetic potential of curcumin in Alzheimer\u2019s disease. BioFactors. 2024;2024:1.","journal-title":"BioFactors"},{"issue":"3","key":"3782_CR6","first-page":"1","volume":"14","author":"AK Vadukoot","year":"2022","unstructured":"Vadukoot AK, Mottemmal S, Vekaria PH. Curcumin as a potential therapeutic agent in certain cancer types. Cureus. 2022;14(3):1.","journal-title":"Cureus"},{"issue":"12","key":"3782_CR7","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1002\/ptr.7983","volume":"37","author":"P Joshi","year":"2023","unstructured":"Joshi P, Verma K, Kumar Semwal D, Dwivedi J, Sharma S. Mechanism insights of curcumin and its analogues in cancer: an update. Phytother Res. 2023;37(12):5435\u201363.","journal-title":"Phytother Res"},{"key":"3782_CR8","doi-asserted-by":"publisher","first-page":"1220983","DOI":"10.3389\/fphar.2023.1220983","volume":"14","author":"Q Shen","year":"2023","unstructured":"Shen Q, Pan X, Li Y, Li J, Zhang C, Jiang X, et al. Lysosomes, curcumin, and anti-tumor effects: How are they linked? Front Pharmacol. 2023;14:1220983.","journal-title":"Front Pharmacol"},{"key":"3782_CR9","doi-asserted-by":"publisher","first-page":"113956","DOI":"10.1016\/j.biopha.2022.113956","volume":"156","author":"T Ming","year":"2022","unstructured":"Ming T, Tao Q, Tang S, Zhao H, Yang H, Liu M, et al. Curcumin: an epigenetic regulator and its application in cancer. Biomed Pharmacother. 2022;156:113956.","journal-title":"Biomed Pharmacother"},{"key":"3782_CR10","first-page":"1","volume":"2024","author":"J Ferrer","year":"2024","unstructured":"Ferrer J, Dimitrova N. Transcription regulation by long non-coding RNAs: mechanisms and disease relevance. Nat Rev Mol Cell Biol. 2024;2024:1\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3782_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canlet.2020.11.048","volume":"501","author":"A Nandwani","year":"2021","unstructured":"Nandwani A, Rathore S, Datta M. LncRNAs in cancer: regulatory and therapeutic implications. Cancer Lett. 2021;501:162\u201371.","journal-title":"Cancer Lett"},{"issue":"2","key":"3782_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3390\/ijms22020632","volume":"22","author":"K Taniue","year":"2021","unstructured":"Taniue K, Akimitsu N. The functions and unique features of LncRNAs in cancer development and tumorigenesis. Int J Mol Sci. 2021;22(2):632.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3782_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13046-022-02488-x","volume":"41","author":"H Khanbabaei","year":"2022","unstructured":"Khanbabaei H, Ebrahimi S, Garc\u00eda-Rodr\u00edguez JL, Ghasemi Z, Pourghadamyari H, Mohammadi M, et al. Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications. J Exp Clin Cancer Res. 2022;41(1):278.","journal-title":"J Exp Clin Cancer Res"},{"key":"3782_CR14","first-page":"645","volume":"22","author":"M Alimohammadi","year":"2023","unstructured":"Alimohammadi M, Gholinezhad Y, Mousavi V, Kahkesh S, Rezaee M, Yaghoobi A, et al. Circular RNAs: novel actors of Wnt signaling pathway in lung cancer progression. Excli j. 2023;22:645\u201369.","journal-title":"Excli j"},{"key":"3782_CR15","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2147\/CMAR.S290975","volume":"2021","author":"J Guo","year":"2021","unstructured":"Guo J, Tong J, Zheng J. Circular RNAs: a promising biomarker for endometrial cancer. Cancer Manag Res. 2021;2021:1651\u201365.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"3782_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/ncrna6040042","volume":"6","author":"J Teppan","year":"2020","unstructured":"Teppan J, Barth DA, Prinz F, Jonas K, Pichler M, Klec C. Involvement of long non-coding RNAs (lncRNAs) in tumor angiogenesis. Non Coding RNA. 2020;6(4):42.","journal-title":"Non Coding RNA"},{"issue":"4","key":"3782_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.gendis.2020.04.009","volume":"8","author":"A Ahadi","year":"2021","unstructured":"Ahadi A. Functional roles of lncRNAs in the pathogenesis and progression of cancer. Genes Dis. 2021;8(4):424\u201337.","journal-title":"Genes Dis"},{"key":"3782_CR18","doi-asserted-by":"publisher","first-page":"660712","DOI":"10.3389\/fonc.2021.660712","volume":"11","author":"H Wang","year":"2021","unstructured":"Wang H, Zhang K, Liu J, Yang J, Tian Y, Yang C, et al. Curcumin regulates cancer progression: focus on ncRNAs and molecular signaling pathways. Front Oncol. 2021;11:660712.","journal-title":"Front Oncol"},{"key":"3782_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pbiomolbio.2021.04.001","volume":"164","author":"AG Shabgah","year":"2021","unstructured":"Shabgah AG, Zarifi SH, Kiapey SSM, Ezzatifar F, Pahlavani N, Soleimani D, et al. Curcumin and cancer; are long non-coding RNAs missing link? Prog Biophys Mol Biol. 2021;164:63\u201371.","journal-title":"Prog Biophys Mol Biol"},{"key":"3782_CR20","first-page":"1","volume":"2024","author":"I Suer","year":"2024","unstructured":"Suer I, Abuaisha A, Kaya M, Abanoz F, Cefle K, Palanduz S, et al. Curcumin suppresses cell viability in breast cancer cell line by affecting the expression of miR-15a-5p. Turk J Biochem. 2024;2024:1.","journal-title":"Turk J Biochem"},{"issue":"7","key":"3782_CR21","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1002\/ptr.7863","volume":"37","author":"L Si","year":"2023","unstructured":"Si L, Zhang L, Xing S, Fang P, Tian X, Liu X, et al. Curcumin as a therapeutic agent in cancer therapy: focusing on its modulatory effects on circular RNAs. Phytother Res. 2023;37(7):3121\u201334.","journal-title":"Phytother Res"},{"issue":"3","key":"3782_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2174\/138945011794815356","volume":"12","author":"H Zhou","year":"2011","unstructured":"Zhou H, Beevers CS, Huang S. The targets of curcumin. Curr Drug Targets. 2011;12(3):332\u201347.","journal-title":"Curr Drug Targets"},{"issue":"12","key":"3782_CR23","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1002\/jcb.26121","volume":"118","author":"J Hajavi","year":"2017","unstructured":"Hajavi J, Momtazi AA, Johnston TP, Banach M, Majeed M, Sahebkar A. Curcumin: a naturally occurring modulator of adipokines in diabetes. J Cell Biochem. 2017;118(12):4170\u201382.","journal-title":"J Cell Biochem"},{"key":"3782_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1196\/annals.1352.010","volume":"1056","author":"S Shishodia","year":"2005","unstructured":"Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann N Y Acad Sci. 2005;1056:206\u201317.","journal-title":"Ann N Y Acad Sci"},{"issue":"13","key":"3782_CR25","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1080\/10408398.2015.1077195","volume":"57","author":"B Kocaadam","year":"2017","unstructured":"Kocaadam B, Sanlier N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. 2017;57(13):2889\u201395.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"3782_CR26","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/cber.191004302168","volume":"43","author":"J Milobedeska","year":"1910","unstructured":"Milobedeska J, Kostanecki V, Lampe V. Structure of curcumin. Ber Dtsch Chem Ges. 1910;43:2163\u201370.","journal-title":"Ber Dtsch Chem Ges"},{"issue":"2","key":"3782_CR27","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/cber.191304602149","volume":"46","author":"V Lampe","year":"1913","unstructured":"Lampe V, Milobedzka J. Studien \u00fcber curcumin. Ber Dtsch Chem Ges. 1913;46(2):2235\u201340.","journal-title":"Ber Dtsch Chem Ges"},{"key":"3782_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.fct.2015.05.022","volume":"83","author":"S Ghosh","year":"2015","unstructured":"Ghosh S, Banerjee S, Sil PC. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: a recent update. Food Chem Toxicol. 2015;83:111\u201324.","journal-title":"Food Chem Toxicol"},{"issue":"4","key":"3782_CR29","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","volume":"75","author":"A Goel","year":"2008","unstructured":"Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as \u201cCurecumin\u201d: from kitchen to clinic. Biochem Pharmacol. 2008;75(4):787\u2013809.","journal-title":"Biochem Pharmacol"},{"issue":"3\u20134","key":"3782_CR30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.saa.2006.08.018","volume":"67","author":"L Shen","year":"2007","unstructured":"Shen L, Ji HF. Theoretical study on physicochemical properties of curcumin. Spectrochim Acta A Mol Biomol Spectrosc. 2007;67(3\u20134):619\u201323.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"5924","key":"3782_CR31","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0140-6736(00)98193-5","volume":"229","author":"A Oppenheimer","year":"1937","unstructured":"Oppenheimer A. Turmeric (curcumin) in biliary diseases. The Lancet. 1937;229(5924):619\u201321.","journal-title":"The Lancet"},{"issue":"5","key":"3782_CR32","doi-asserted-by":"publisher","first-page":"9183","DOI":"10.3390\/molecules20059183","volume":"20","author":"Y He","year":"2015","unstructured":"He Y, Yue Y, Zheng X, Zhang K, Chen S, Du Z. Curcumin, inflammation, and chronic diseases: How are they linked? Molecules. 2015;20(5):9183\u2013213.","journal-title":"Molecules"},{"issue":"12","key":"3782_CR33","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1002\/mnfr.201500370","volume":"59","author":"XQ Ding","year":"2015","unstructured":"Ding XQ, Gu TT, Wang W, Song L, Chen TY, Xue QC, et al. Curcumin protects against fructose-induced podocyte insulin signaling impairment through upregulation of miR-206. Mol Nutr Food Res. 2015;59(12):2355\u201370.","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"3782_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.tips.2008.11.002","volume":"30","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci. 2009;30(2):85\u201394.","journal-title":"Trends Pharmacol Sci"},{"issue":"23","key":"3782_CR35","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.2174\/1568026615666150619142519","volume":"15","author":"SF Nabavi","year":"2015","unstructured":"Nabavi SF, Thiagarajan R, Rastrelli L, Daglia M, Sobarzo-Sanchez E, Alinezhad H, et al. Curcumin: a natural product for diabetes and its complications. Curr Top Med Chem. 2015;15(23):2445\u201355.","journal-title":"Curr Top Med Chem"},{"issue":"6","key":"3782_CR36","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807\u201318.","journal-title":"Mol Pharm"},{"key":"3782_CR37","first-page":"3656419","volume":"2020","author":"NE Rainey","year":"2020","unstructured":"Rainey NE, Moustapha A, Petit PXJOM, Longevity C. Curcumin, a multifaceted hormetic agent, mediates an intricate crosstalk between mitochondrial turnover, autophagy, and apoptosis. Oxid Med Cell Long. 2020;2020:3656419.","journal-title":"Oxid Med Cell Long"},{"issue":"11","key":"3782_CR38","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1136\/gut.2008.152496","volume":"57","author":"DG Binion","year":"2008","unstructured":"Binion DG, Otterson MF, Rafiee PJG. Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. Gut. 2008;57(11):1509\u201317.","journal-title":"Gut"},{"key":"3782_CR39","doi-asserted-by":"crossref","unstructured":"Bhandarkar SS, Arbiser JLJTmt, health tuoci, disease. Curcumin as an inhibitor of angiogenesis. 2007:185\u201395.","DOI":"10.1007\/978-0-387-46401-5_7"},{"issue":"21","key":"3782_CR40","doi-asserted-by":"publisher","first-page":"7410","DOI":"10.3390\/molecules27217410","volume":"27","author":"MAI Alhasawi","year":"2022","unstructured":"Alhasawi MAI, Aatif M, Muteeb G, Alam MW, Oirdi ME, Farhan MJM. Curcumin and its derivatives induce apoptosis in human cancer cells by mobilizing and redox cycling genomic copper ions. Molecule. 2022;27(21):7410.","journal-title":"Molecule"},{"issue":"9","key":"3782_CR41","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3390\/life12091427","volume":"12","author":"SA Gabr","year":"2022","unstructured":"Gabr SA, Elsaed WM, Eladl MA, El-Sherbiny M, Ebrahim HA, Asseri SM, et al. Curcumin modulates oxidative stress, fibrosis, and apoptosis in drug-resistant cancer cell lines. Life. 2022;12(9):1427.","journal-title":"Life"},{"issue":"29","key":"3782_CR42","doi-asserted-by":"publisher","first-page":"10375","DOI":"10.1039\/C7NR02770B","volume":"9","author":"I Kalashnikova","year":"2017","unstructured":"Kalashnikova I, Mazar J, Neal CJ, Rosado AL, Das S, Westmoreland TJ, et al. Nanoparticle delivery of curcumin induces cellular hypoxia and ROS-mediated apoptosis via modulation of Bcl-2\/Bax in human neuroblastoma. Nanoscale. 2017;9(29):10375\u201387.","journal-title":"Nanoscale"},{"key":"3782_CR43","first-page":"1","volume":"2022","author":"G Yavuz T\u00fcrel","year":"2022","unstructured":"Yavuz T\u00fcrel G, \u015eahin Calapo\u011flu N, Bayram D, \u00d6zg\u00f6\u00e7men M, To\u011fay VA, Evgen T\u00fcl\u00fcceo\u011flu EJMBR. Curcumin induces apoptosis through caspase dependent pathway in human colon carcinoma cells. Mol Biol Rep. 2022;2022:1\u201310.","journal-title":"Mol Biol Rep"},{"issue":"4","key":"3782_CR44","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1158\/1940-6207.CAPR-13-0387","volume":"7","author":"T-G Lim","year":"2014","unstructured":"Lim T-G, Lee S-Y, Huang Z, Lim DY, Chen H, Jung SK, et al. Curcumin suppresses proliferation of colon cancer cells by targeting CDK2. Cancer Prev Res. 2014;7(4):466\u201374.","journal-title":"Cancer Prev Res"},{"issue":"4","key":"3782_CR45","first-page":"1","volume":"24","author":"G \u00c7al\u0131ba\u015f\u0131 Ko\u00e7al","year":"2019","unstructured":"\u00c7al\u0131ba\u015f\u0131 Ko\u00e7al G, Pakdemirli A, Bayrak S, Ozupek N, Sever T, Ba\u015fb\u0131nar Y, et al. Curcumin effects on cell proliferation, angiogenesis and metastasis in colorectal cancer. J BUON. 2019;24(4):1.","journal-title":"J BUON"},{"issue":"5","key":"3782_CR46","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.1002\/jcp.27482","volume":"234","author":"C Jin","year":"2019","unstructured":"Jin C, Wang A, Liu L, Wang G, Li G. Hsa_circ_0136666 promotes the proliferation and invasion of colorectal cancer through miR-136\/SH2B1 axis. J Cell Physiol. 2019;234(5):7247\u201356.","journal-title":"J Cell Physiol"},{"issue":"6","key":"3782_CR47","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen L-L, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023;24(6):430\u201347.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3782_CR48","first-page":"Ch. 2","volume-title":"Recent advances in noncoding RNAs","author":"S Ishteyaq Majeed","year":"2022","unstructured":"Ishteyaq Majeed S, Mashooq Ahmad D, Kaiser Ahmad B, Tashook Ahmad D, Fayaz A, Syed Mudasir A. Long non-coding RNAs: biogenesis, mechanism of action and role in different biological and pathological processes. In: L\u00fctfi T, editor. Recent advances in noncoding RNAs. Rijeka: IntechOpen; 2022. p. Ch. 2."},{"key":"3782_CR49","first-page":"1","volume":"2024","author":"N Hedayati","year":"2024","unstructured":"Hedayati N, Babaei Aghdam Z, Rezaee M, Mousavi Dehmordi R, Alimohammadi M, Mafi A. Recent insights into the angioregulatory role of long non-coding RNAs and circular RNAs in gliomas: from signaling pathways to clinical aspects. Curr Med Chem. 2024;2024:1.","journal-title":"Curr Med Chem"},{"issue":"4","key":"3782_CR50","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.cell.2017.04.011","volume":"169","author":"Y-H Xing","year":"2017","unstructured":"Xing Y-H, Yao R-W, Zhang Y, Guo C-J, Jiang S, Xu G, et al. SLERT regulates DDX21 rings associated with Pol I transcription. Cell. 2017;169(4):664-78. e16.","journal-title":"Cell"},{"issue":"11","key":"3782_CR51","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3390\/cancers13112643","volume":"13","author":"L Borkiewicz","year":"2021","unstructured":"Borkiewicz L, Kalafut J, Dudziak K, Przybyszewska-Podstawka A, Telejko I. Decoding LncRNAs. Cancers. 2021;13(11):2643.","journal-title":"Cancers"},{"issue":"9","key":"3782_CR52","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1073\/pnas.1222643110","volume":"110","author":"L Sun","year":"2013","unstructured":"Sun L, Goff LA, Trapnell C, Alexander R, Lo KA, Hacisuleyman E, et al. Long noncoding RNAs regulate adipogenesis. Proc Natl Acad Sci. 2013;110(9):3387\u201392.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"3782_CR53","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo C-J, Chen L-L, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"3782_CR54","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cell.2018.03.064","volume":"173","author":"M Jiang","year":"2018","unstructured":"Jiang M, Zhang S, Yang Z, Lin H, Zhu J, Liu L, et al. Self-recognition of an inducible host lncRNA by RIG-I feedback restricts innate immune response. Cell. 2018;173(4):906-19. e13.","journal-title":"Cell"},{"issue":"2","key":"3782_CR55","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.celrep.2018.03.044","volume":"23","author":"I Sanli","year":"2018","unstructured":"Sanli I, Lalev\u00e9e S, Cammisa M, Perrin A, Rage F, Ll\u00e8res D, et al. Meg3 non-coding RNA expression controls imprinting by preventing transcriptional upregulation in cis. Cell Rep. 2018;23(2):337\u201348.","journal-title":"Cell Rep"},{"issue":"7629","key":"3782_CR56","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature20149","volume":"539","author":"JM Engreitz","year":"2016","unstructured":"Engreitz JM, Haines JE, Perez EM, Munson G, Chen J, Kane M, et al. Local regulation of gene expression by lncRNA promoters, transcription and splicing. Nature. 2016;539(7629):452\u20135.","journal-title":"Nature"},{"key":"3782_CR57","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00109-014-1131-8","volume":"92","author":"PG Maass","year":"2014","unstructured":"Maass PG, Luft FC, B\u00e4hring SJJ. Long non-coding RNA in health and disease. J Mol Med. 2014;92:337\u201346.","journal-title":"J Mol Med"},{"key":"3782_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-020-00640-3","volume":"27","author":"C-Y Guh","year":"2020","unstructured":"Guh C-Y, Hsieh Y-H, Chu H-PJJ. Functions and properties of nuclear lncRNAs\u2014from systematically mapping the interactomes of lncRNAs. J Biomed Sci. 2020;27:1\u201314.","journal-title":"J Biomed Sci"},{"issue":"1","key":"3782_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-020-01287-2","volume":"19","author":"S Chen","year":"2020","unstructured":"Chen S, Shen XJM. Long noncoding RNAs: functions and mechanisms in colon cancer. Mol Cancer. 2020;19(1):167.","journal-title":"Mol Cancer"},{"key":"3782_CR60","doi-asserted-by":"publisher","first-page":"598817","DOI":"10.3389\/fonc.2020.598817","volume":"10","author":"N Gao","year":"2020","unstructured":"Gao N, Li Y, Li J, Gao Z, Yang Z, Li Y, et al. Long non-coding RNAs: the regulatory mechanisms, research strategies, and future directions in cancers. Front Oncol. 2020;10:598817.","journal-title":"Front Oncol"},{"issue":"3","key":"3782_CR61","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1080\/21655979.2021.1987124","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, Jiang Y. Downregulation of circular RNA circ-HN1 suppressed the progression of gastric cancer through the miR-485-5p\/GSK3A pathway. Bioengineered. 2022;13(3):5675\u201384.","journal-title":"Bioengineered"},{"issue":"7","key":"3782_CR62","doi-asserted-by":"publisher","first-page":"e4116","DOI":"10.1002\/cbf.4116","volume":"42","author":"A Jafarzadeh","year":"2024","unstructured":"Jafarzadeh A, Naseri B, Khorramdelazad H, Jafarzadeh S, Ghorbaninezhad F, Asgari Z, et al. Reciprocal interactions between apelin and noncoding RNAs in cancer progression. Cell Biochem Funct. 2024;42(7):e4116.","journal-title":"Cell Biochem Funct"},{"issue":"5","key":"3782_CR63","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3727\/096504016X14549667334007","volume":"23","author":"J Li","year":"2016","unstructured":"Li J, Meng H, Bai Y, Wang KJO. Regulation of lncRNA and its role in cancer metastasis. Oncol Res. 2016;23(5):205.","journal-title":"Oncol Res"},{"issue":"6270","key":"3782_CR64","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/science.aad4076","volume":"351","author":"BR Nelson","year":"2016","unstructured":"Nelson BR, Makarewich CA, Anderson DM, Winders BR, Troupes CD, Wu F, et al. A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle. Science. 2016;351(6270):271\u20135.","journal-title":"Science"},{"issue":"1","key":"3782_CR65","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/s42003-022-04262-3","volume":"5","author":"L Ren","year":"2022","unstructured":"Ren L, Jiang Q, Mo L, Tan L, Dong Q, Meng L, et al. Mechanisms of circular RNA degradation. Commun Biol. 2022;5(1):1355.","journal-title":"Commun Biol"},{"issue":"3","key":"3782_CR66","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41418-022-00948-7","volume":"29","author":"S Misir","year":"2022","unstructured":"Misir S, Wu N, Yang BBJCD. Differentiation. Specific expression and functions of circular RNAs. Cell Death Differ. 2022;29(3):481\u201391.","journal-title":"Cell Death Differ"},{"key":"3782_CR67","doi-asserted-by":"publisher","first-page":"1224138","DOI":"10.3389\/fonc.2023.1224138","volume":"13","author":"A Mafi","year":"2023","unstructured":"Mafi A, Rismanchi H, Malek Mohammadi M, Hedayati N, Ghorbanhosseini SS, Hosseini SA, et al. A spotlight on the interplay between Wnt\/\u03b2-catenin signaling and circular RNAs in hepatocellular carcinoma progression. Front Oncol. 2023;13:1224138.","journal-title":"Front Oncol"},{"issue":"1","key":"3782_CR68","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12929-019-0523-z","volume":"26","author":"C-Y Yu","year":"2019","unstructured":"Yu C-Y, Kuo H-CJJ. The emerging roles and functions of circular RNAs and their generation. J Biomed Sci. 2019;26(1):29.","journal-title":"J Biomed Sci"},{"issue":"9","key":"3782_CR69","first-page":"636","volume":"21","author":"S Crunkhorn","year":"2022","unstructured":"Crunkhorn S. Improving circular RNA protein yields. Nat Rev Drug Discovery. 2022;21(9):636.","journal-title":"Nat Rev Drug Discovery"},{"issue":"11","key":"3782_CR70","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1007\/s12094-023-03178-6","volume":"25","author":"F Ghaedrahmati","year":"2023","unstructured":"Ghaedrahmati F, Nasrolahi A, Najafi S, Mighani M, Anbiyaee O, Haybar H, et al. Circular RNAs-mediated angiogenesis in human cancers. Clin Transl Oncol. 2023;25(11):3101\u201321.","journal-title":"Clin Transl Oncol"},{"key":"3782_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-021-01446-z","volume":"20","author":"V Singh","year":"2021","unstructured":"Singh V, Uddin MH, Zonder JA, Azmi AS, Balasubramanian SKJM. Circular RNAs in acute myeloid leukemia. Mol Cancer. 2021;20:1\u201310.","journal-title":"Mol Cancer"},{"issue":"1","key":"3782_CR72","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41392-023-01561-x","volume":"8","author":"D Niu","year":"2023","unstructured":"Niu D, Wu Y, Lian J. Circular RNA vaccine in disease prevention and treatment. Signal Transduct Target Ther. 2023;8(1):341.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"3782_CR73","doi-asserted-by":"publisher","first-page":"e13540","DOI":"10.1111\/eci.13540","volume":"51","author":"J Yu","year":"2021","unstructured":"Yu J, Chen X, Li J, Wang F. CircRUNX1 functions as an oncogene in colorectal cancer by regulating circRUNX1\/miR-485-5p\/SLC38A1 axis. Eur J Clin Invest. 2021;51(7):e13540.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"3782_CR74","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41419-020-03350-8","volume":"12","author":"J Chu","year":"2021","unstructured":"Chu J, Tao L, Yao T, Chen Z, Lu X, Gao L, et al. Circular RNA circRUNX1 promotes papillary thyroid cancer progression and metastasis by sponging MiR-296-3p and regulating DDHD2 expression. Cell Death Dis. 2021;12(1):112.","journal-title":"Cell Death Dis"},{"key":"3782_CR75","first-page":"1","volume":"2023","author":"Y Wang","year":"2023","unstructured":"Wang Y, Li H, Chen W, Huang X, Fan R, Xu M, et al. CircRUNX1 drives the malignant phenotypes of lung adenocarcinoma through mediating the miR-5195\u20133p\/HMGB3 network. Gener Thor Cardiovasc Surg. 2023;2023:1\u201312.","journal-title":"Gener Thor Cardiovasc Surg"},{"key":"3782_CR76","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.biocel.2016.03.017","volume":"75","author":"Y Luo","year":"2016","unstructured":"Luo Y, Ye G-Y, Qin S-L, Mu Y-F, Zhang L, Qi Y, et al. High expression of Rab3D predicts poor prognosis and associates with tumor progression in colorectal cancer. Int J Biochem Cell Biol. 2016;75:53\u201362.","journal-title":"Int J Biochem Cell Biol"},{"key":"3782_CR77","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.biopha.2017.04.010","volume":"91","author":"J Zhang","year":"2017","unstructured":"Zhang J, Kong R, Sun L. Silencing of Rab3D suppresses the proliferation and invasion of esophageal squamous cell carcinoma cells. Biomed Pharmacother. 2017;91:402\u20137.","journal-title":"Biomed Pharmacother"},{"key":"3782_CR78","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.2147\/OTT.S243533","volume":"2020","author":"L Li","year":"2020","unstructured":"Li L, Wan K, Xiong L, Liang S, Tou F, Guo S. CircRNA hsa_circ_0087862 acts as an oncogene in non-small cell lung cancer by targeting miR-1253\/RAB3D axis. Onco Targets Ther. 2020;2020:2873\u201386.","journal-title":"Onco Targets Ther"},{"issue":"5","key":"3782_CR79","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/1759-7714.14773","volume":"14","author":"X Wu","year":"2023","unstructured":"Wu X, Chen H, Liu N, Liu S, Lin G. Curcumin suppresses lung cancer progression via circRUNX1 mediated miR-760\/RAB3D axis. Thor Cancer. 2023;14(5):506\u201316.","journal-title":"Thor Cancer"},{"issue":"14","key":"3782_CR80","doi-asserted-by":"publisher","first-page":"14329","DOI":"10.18632\/aging.103472","volume":"12","author":"S Chen","year":"2020","unstructured":"Chen S, Lu S, Yao Y, Chen J, Yang G, Tu L, et al. Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging. Aging (Albany). 2020;12(14):14329.","journal-title":"Aging (Albany)"},{"key":"3782_CR81","doi-asserted-by":"publisher","first-page":"111439","DOI":"10.1016\/j.biopha.2021.111439","volume":"138","author":"X Xu","year":"2021","unstructured":"Xu X, Zhang X, Zhang Y, Wang Z. Curcumin suppresses the malignancy of non-small cell lung cancer by modulating the circ-PRKCA\/miR-384\/ITGB1 pathway. Biomed Pharmacother. 2021;138:111439.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3782_CR82","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s13577-019-00287-9","volume":"33","author":"Q Ma","year":"2020","unstructured":"Ma Q, Qi X, Lin X, Li L, Chen L, Hu W. LncRNA SNHG3 promotes cell proliferation and invasion through the miR-384\/hepatoma-derived growth factor axis in breast cancer. Hum Cell. 2020;33(1):232\u201342.","journal-title":"Hum Cell"},{"key":"3782_CR83","doi-asserted-by":"publisher","first-page":"153303382090912","DOI":"10.1177\/1533033820909125","volume":"19","author":"Y Tan","year":"2020","unstructured":"Tan Y, Chen L, Li S, Hao H, Zhang D. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3. Technol Cancer Res Treat. 2020;19:1533033820909125.","journal-title":"Technol Cancer Res Treat"},{"key":"3782_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-018-0628-6","volume":"18","author":"Y-X Wang","year":"2018","unstructured":"Wang Y-X, Zhu H-F, Zhang Z-Y, Ren F, Hu Y-H. MiR-384 inhibits the proliferation of colorectal cancer by targeting AKT3. Cancer Cell Int. 2018;18:1\u201310.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"3782_CR85","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1080\/21691401.2019.1601099","volume":"47","author":"Y Wang","year":"2019","unstructured":"Wang Y, Huang H, Li Y. Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP. Artif Cells Nanomed Biotechnol. 2019;47(1):1458\u201365.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"8","key":"3782_CR86","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1111\/cas.13693","volume":"109","author":"R Kawahara","year":"2018","unstructured":"Kawahara R, Niwa Y, Simizu S. Integrin \u03b21 is an essential factor in vasculogenic mimicry of human cancer cells. Cancer Sci. 2018;109(8):2490\u20136.","journal-title":"Cancer Sci"},{"issue":"1","key":"3782_CR87","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1038\/s41598-018-20161-2","volume":"8","author":"T Pellinen","year":"2018","unstructured":"Pellinen T, Blom S, S\u00e1nchez S, V\u00e4lim\u00e4ki K, Mpindi J-P, Azegrouz H, et al. ITGB1-dependent upregulation of Caveolin-1 switches TGF\u03b2 signalling from tumour-suppressive to oncogenic in prostate cancer. Sci Rep. 2018;8(1):2338.","journal-title":"Sci Rep"},{"issue":"9","key":"3782_CR88","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/ijc.30854","volume":"141","author":"S Laudato","year":"2017","unstructured":"Laudato S, Patil N, Abba ML, Leupold JH, Benner A, Gaiser T, et al. P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1. Int J Cancer. 2017;141(9):1879\u201390.","journal-title":"Int J Cancer"},{"issue":"4","key":"3782_CR89","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3390\/ijms19041116","volume":"19","author":"L Gou","year":"2018","unstructured":"Gou L, Liu M, Xia J, Wan Q, Jiang Y, Sun S, et al. BMP9 promotes the proliferation and migration of bladder cancer cells through up-regulating lncRNA UCA1. Int J Mol Sci. 2018;19(4):1116.","journal-title":"Int J Mol Sci"},{"key":"3782_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-021-00275-8","volume":"26","author":"A Yang","year":"2021","unstructured":"Yang A, Liu X, Liu P, Feng Y, Liu H, Gao S, et al. LncRNA UCA1 promotes development of gastric cancer via the miR-145\/MYO6 axis. Cell Mol Biol Lett. 2021;26:1\u201318.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"3782_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep23892","volume":"6","author":"Z Bian","year":"2016","unstructured":"Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu Y, et al. LncRNA\u2014UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep. 2016;6(1):1\u201312.","journal-title":"Sci Rep"},{"key":"3782_CR92","first-page":"65","volume":"2019","author":"L Chen","year":"2019","unstructured":"Chen L, Cao P, Wu Q, Guo Y, Yang Y, Chen F. Overexpression of LncRNA-UCA1 correlates with lung adenocarcinoma progression and poor prognosis. Clin Lab. 2019;2019:65.","journal-title":"Clin Lab"},{"key":"3782_CR93","doi-asserted-by":"publisher","first-page":"10897","DOI":"10.2147\/CMAR.S270396","volume":"2020","author":"H-Z Wang","year":"2020","unstructured":"Wang H-Z, Liu L, Xu Y, Zhang G-Y, Wang Y-Y. LncRNA UCA1 affects the cell proliferation, migration, invasion and apoptosis of hepatic carcinoma cells by targeting MicroRNA-193a-3p. Cancer Manag Res. 2020;2020:10897\u2013907.","journal-title":"Cancer Manag Res"},{"key":"3782_CR94","doi-asserted-by":"publisher","first-page":"618472","DOI":"10.3389\/fonc.2020.618472","volume":"10","author":"L Jiang","year":"2020","unstructured":"Jiang L, Wan Y, Feng Z, Liu D, Ouyang L, Li Y, et al. Long noncoding RNA UCA1 is related to autophagy and apoptosis in endometrial stromal cells. Front Oncol. 2020;10:618472.","journal-title":"Front Oncol"},{"issue":"7","key":"3782_CR95","first-page":"402","volume":"73","author":"W-H Wang","year":"2018","unstructured":"Wang W-H, Chen J, Zhang B-R, Lu S-J, Wang F, Peng L, et al. Curcumin inhibits proliferation and enhances apoptosis in A549 cells by downregulating lncRNA UCA1. Die Pharm Int J Pharmaceut Sci. 2018;73(7):402\u20137.","journal-title":"Die Pharm Int J Pharmaceut Sci"},{"key":"3782_CR96","doi-asserted-by":"publisher","first-page":"109129","DOI":"10.1016\/j.biopha.2019.109129","volume":"118","author":"S Ghafouri-Fard","year":"2019","unstructured":"Ghafouri-Fard S, Taheri M. Maternally expressed gene 3 (MEG3): a tumor suppressor long non coding RNA. Biomed Pharmacother. 2019;118:109129.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"3782_CR97","first-page":"3326","volume":"9","author":"Z Wu","year":"2017","unstructured":"Wu Z, He Y, Li D, Fang X, Shang T, Zhang H, et al. Long noncoding RNA MEG3 suppressed endothelial cell proliferation and migration through regulating miR-21. Ame J Transl Res. 2017;9(7):3326.","journal-title":"Ame J Transl Res"},{"issue":"7","key":"3782_CR98","first-page":"4089","volume":"11","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liu J, Lv Y, Zhang C, Guo S. LncRNA meg3 suppresses hepatocellular carcinoma in vitro and vivo studies. Am J Transl Res. 2019;11(7):4089.","journal-title":"Am J Transl Res"},{"issue":"2","key":"3782_CR99","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/jcp.29025","volume":"235","author":"G Shan","year":"2020","unstructured":"Shan G, Tang T, Xia Y, Qian HJ. MEG3 interacted with miR-494 to repress bladder cancer progression through targeting PTEN. J Cell Physiol. 2020;235(2):1120\u20138.","journal-title":"J Cell Physiol"},{"key":"3782_CR100","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.2147\/OTT.S146423","volume":"2017","author":"P Wang","year":"2017","unstructured":"Wang P, Chen D, Ma H, Li Y. LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p\/SOX7 axis. Onco Targets Ther. 2017;2017:5137\u201349.","journal-title":"Onco Targets Ther"},{"issue":"4","key":"3782_CR101","first-page":"1","volume":"22","author":"H Xia","year":"2018","unstructured":"Xia H, Qu X-L, Liu L-Y, Qian D-H, Jing H-Y. LncRNA MEG3 promotes the sensitivity of vincristine by inhibiting autophagy in lung cancer chemotherapy. Eur Rev Med Pharmacol Sci. 2018;22(4):1.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"3782_CR102","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3390\/pharmaceutics15082090","volume":"15","author":"Z Sirhan","year":"2023","unstructured":"Sirhan Z, Alojair R, Thyagarajan A, Sahu RP. Therapeutic implications of PTEN in non-small cell lung cancer. Pharmaceutics. 2023;15(8):2090.","journal-title":"Pharmaceutics"},{"key":"3782_CR103","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1007\/s12094-020-02531-3","volume":"23","author":"L Gao","year":"2021","unstructured":"Gao L, Shao T, Zheng W, Ding J. Curcumin suppresses tumor growth of gemcitabine-resistant non-small cell lung cancer by regulating lncRNA-MEG3 and PTEN signaling. Clin Transl Oncol. 2021;23:1386\u201393.","journal-title":"Clin Transl Oncol"},{"key":"3782_CR104","doi-asserted-by":"crossref","unstructured":"Jiang B, Zhu H, Tang L, Gao T, Zhou Y, Gong F, et al. Apatinib inhibits stem properties and malignant biological behaviors of breast cancer stem cells by blocking wnt\/\u03b2-catenin signal pathway through downregulating LncRNA ROR. Anti-Cancer Agents Med Chem (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2022;22(9):1723\u201334.","DOI":"10.2174\/1871520621666210412103849"},{"issue":"1","key":"3782_CR105","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ygeno.2020.10.016","volume":"113","author":"X Hua","year":"2021","unstructured":"Hua X, Chen J, Ge S, Xiao H, Zhang L, Liang C. Integrated analysis of the functions of RNA binding proteins in clear cell renal cell carcinoma. Genomics. 2021;113(1):850\u201360.","journal-title":"Genomics"},{"issue":"6","key":"3782_CR106","first-page":"1","volume":"38","author":"J Li","year":"2019","unstructured":"Li J, Zhang S, Wu L, Pei M. Interaction between LncRNA-ROR and miR-145 contributes to epithelial-mesenchymal transition of ovarian cancer cells. Gener Physiol Biophys. 2019;38(6):1.","journal-title":"Gener Physiol Biophys"},{"issue":"1","key":"3782_CR107","doi-asserted-by":"publisher","first-page":"107327482090469","DOI":"10.1177\/1073274820904694","volume":"27","author":"S Wang","year":"2020","unstructured":"Wang S, Chen W, Yu H, Song Z, Li Q, Shen X, et al. lncRNA ROR promotes gastric cancer drug resistance. Cancer Control. 2020;27(1):1073274820904694.","journal-title":"Cancer Control"},{"issue":"3","key":"3782_CR108","doi-asserted-by":"publisher","first-page":"312","DOI":"10.15283\/ijsc20097","volume":"13","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Han Z, Zhu Y, Chen J, Li W. The role and specific mechanism of OCT4 in cancer stem cells: a review. Int J Stem Cells. 2020;13(3):312.","journal-title":"Int J Stem Cells"},{"key":"3782_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2016.10.003","volume":"51","author":"ES Villodre","year":"2016","unstructured":"Villodre ES, Kipper FC, Pereira MB, Lenz G. Roles of OCT4 in tumorigenesis, cancer therapy resistance and prognosis. Cancer Treat Rev. 2016;51:1\u20139.","journal-title":"Cancer Treat Rev"},{"key":"3782_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-13-82","volume":"13","author":"L Cao","year":"2013","unstructured":"Cao L, Li C, Shen S, Yan Y, Ji W, Wang J, et al. OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma. BMC Cancer. 2013;13:1\u201313.","journal-title":"BMC Cancer"},{"issue":"1","key":"3782_CR111","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.canlet.2014.07.049","volume":"354","author":"Z Li","year":"2014","unstructured":"Li Z, Li X, Li C, Su Y, Fang W, Zhong C, et al. Transcription factor OCT4 promotes cell cycle progression by regulating CCND1 expression in esophageal carcinoma. Cancer Lett. 2014;354(1):77\u201386.","journal-title":"Cancer Lett"},{"key":"3782_CR112","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.gene.2017.08.008","volume":"631","author":"T Liu","year":"2017","unstructured":"Liu T, Chi H, Chen J, Chen C, Huang Y, Xi H, et al. Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR. Gene. 2017;631:29\u201338.","journal-title":"Gene"},{"issue":"10","key":"3782_CR113","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1002\/jcb.25988","volume":"118","author":"W Wei","year":"2017","unstructured":"Wei W, Liu Y, Lu Y, Yang B, Tang L. LncRNA XIST promotes pancreatic cancer proliferation through miR-133a\/EGFR. J Cell Biochem. 2017;118(10):3349\u201358.","journal-title":"J Cell Biochem"},{"issue":"6","key":"3782_CR114","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.18632\/aging.102673","volume":"12","author":"X Xu","year":"2020","unstructured":"Xu X, Zhou X, Chen Z, Gao C, Zhao L, Cui Y. Silencing of lncRNA XIST inhibits non-small cell lung cancer growth and promotes chemosensitivity to cisplatin. Aging (Albany). 2020;12(6):4711.","journal-title":"Aging (Albany)"},{"issue":"7","key":"3782_CR115","first-page":"3501","volume":"12","author":"Y Zong","year":"2020","unstructured":"Zong Y, Zhang Y, Hou D, Xu J, Cui F, Qin Y, et al. The lncRNA XIST promotes the progression of breast cancer by sponging miR-125b-5p to modulate NLRC5. Am J Transl Res. 2020;12(7):3501.","journal-title":"Am J Transl Res"},{"issue":"3","key":"3782_CR116","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ajg.2020.07.010","volume":"21","author":"W Zheng","year":"2020","unstructured":"Zheng W, Li J, Zhou X, Cui L, Wang Y. The lncRNA XIST promotes proliferation, migration and invasion of gastric cancer cells by targeting miR-337. Arab J Gastroenterol. 2020;21(3):199\u2013206.","journal-title":"Arab J Gastroenterol"},{"key":"3782_CR117","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.biopha.2018.05.053","volume":"105","author":"H Zhu","year":"2018","unstructured":"Zhu H, Zheng T, Yu J, Zhou L, Wang L. LncRNA XIST accelerates cervical cancer progression via upregulating Fus through competitively binding with miR-200a. Biomed Pharmacother. 2018;105:789\u201397.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"3782_CR118","first-page":"7481","volume":"10","author":"J Zhang","year":"2017","unstructured":"Zhang J, Cao Z, Ding X, Wei X, Zhang X, Hou J, et al. The lncRNA XIST regulates the tumorigenicity of renal cell carcinoma cells via the miR-302c\/SDC1 axis. Int J Clin Exp Pathol. 2017;10(7):7481.","journal-title":"Int J Clin Exp Pathol"},{"key":"3782_CR119","doi-asserted-by":"publisher","first-page":"645647","DOI":"10.3389\/fcell.2021.645647","volume":"9","author":"W Wang","year":"2021","unstructured":"Wang W, Min L, Qiu X, Wu X, Liu C, Ma J, et al. Biological function of long non-coding RNA (LncRNA) Xist. Front Cell Develop Biol. 2021;9:645647.","journal-title":"Front Cell Develop Biol"},{"issue":"3","key":"3782_CR120","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.bbrc.2019.01.116","volume":"510","author":"K Sun","year":"2019","unstructured":"Sun K, Jia Z, Duan R, Yan Z, Jin Z, Yan L, et al. Long non-coding RNA XIST regulates miR-106b-5p\/P21 axis to suppress tumor progression in renal cell carcinoma. Biochem Biophys Res Commun. 2019;510(3):416\u201320.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"3782_CR121","doi-asserted-by":"publisher","first-page":"12684","DOI":"10.1002\/jcb.28536","volume":"120","author":"LH Liu","year":"2019","unstructured":"Liu LH, Tian QQ, Liu J, Zhou Y, Yong H. Upregulation of hsa_circ_0136666 contributes to breast cancer progression by sponging miR-1299 and targeting CDK6. J Cell Biochem. 2019;120(8):12684\u201393.","journal-title":"J Cell Biochem"},{"issue":"1","key":"3782_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13018-022-03303-1","volume":"17","author":"X Gao","year":"2022","unstructured":"Gao X, Xu N, Miao K, Huang G, Huang Y. Circ_0136666 aggravates osteosarcoma development through mediating miR-1244\/CEP55 axis. J Orthop Surg Res. 2022;17(1):1\u201314.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"3782_CR123","doi-asserted-by":"publisher","first-page":"e1822","DOI":"10.1002\/wrna.1822","volume":"15","author":"T Hu","year":"2024","unstructured":"Hu T, Shi R, Gu Y, Zhou H, Fang Y, Xu T, et al. Cancer-derived non-coding RNAs endow tumor microenvironment with immunosuppressive properties. Wiley Interdiscip Rev RNA. 2024;15(1):e1822.","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"13","key":"3782_CR124","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1158\/0008-5472.CAN-16-3199","volume":"77","author":"D Wang","year":"2017","unstructured":"Wang D, Sun H, Wei J, Cen B, DuBois RN. CXCL1 is critical for premetastatic niche formation and metastasis in colorectal cancer. Can Res. 2017;77(13):3655\u201365.","journal-title":"Can Res"},{"issue":"12","key":"3782_CR125","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.4251\/wjgo.v15.i12.2120","volume":"15","author":"S Chen","year":"2023","unstructured":"Chen S, Li W, Ning C-G, Wang F, Wang L-X, Liao C, et al. Hsa_circ_0136666 mediates the antitumor effect of curcumin in colorectal carcinoma by regulating CXCL1 via miR-1301-3p. World J Gastrointest Oncol. 2023;15(12):2120.","journal-title":"World J Gastrointest Oncol"},{"key":"3782_CR126","doi-asserted-by":"publisher","first-page":"9405","DOI":"10.2147\/CMAR.S260129","volume":"2020","author":"H Wang","year":"2020","unstructured":"Wang H, Cai X, Ma L. Curcumin modifies epithelial-mesenchymal transition in colorectal cancer through regulation of miR-200c\/EPM5. Cancer Manag Res. 2020;2020:9405\u201315.","journal-title":"Cancer Manag Res"},{"issue":"2","key":"3782_CR127","first-page":"219","volume":"73","author":"Z Wu","year":"2022","unstructured":"Wu Z, Zhao X, Sun Y, Yu H. Curcumin suppresses colorectal cancer development with epithelial-mesenchymal transition via modulating circular RNA HN1\/miR-302a-3p\/PIK3R3 axis. J Physiol Pharmacol. 2022;73(2):219\u201331.","journal-title":"J Physiol Pharmacol"},{"issue":"7","key":"3782_CR128","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1080\/10715762.2021.1947503","volume":"55","author":"D Wei","year":"2021","unstructured":"Wei D, Ke Y-Q, Duan P, Zhou L, Wang C-Y, Cao P. MicroRNA-302a-3p induces ferroptosis of non-small cell lung cancer cells via targeting ferroportin. Free Radical Res. 2021;55(7):722\u201331.","journal-title":"Free Radical Res"},{"issue":"3","key":"3782_CR129","first-page":"1580","volume":"13","author":"Y Xu","year":"2021","unstructured":"Xu Y, Xu X, Ocansey DKW, Cao H, Qiu W, Tu Q, et al. CircRNAs as promising biomarkers of inflammatory bowel disease and its associated-colorectal cancer. Am J Transl Res. 2021;13(3):1580.","journal-title":"Am J Transl Res"},{"key":"3782_CR130","doi-asserted-by":"publisher","first-page":"e86221","DOI":"10.1590\/fst.86221","volume":"42","author":"X-F Sun","year":"2021","unstructured":"Sun X-F, Li L, Liu Y-B. Curcumin played an anti-cancer role in colorectal cancer via mediating circ_KIAA1199-related regulatory axis. Food Sci Technol. 2021;42:e86221.","journal-title":"Food Sci Technol"},{"issue":"10","key":"3782_CR131","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.3390\/cimb44100309","volume":"44","author":"M Sikora-Skrabaka","year":"2022","unstructured":"Sikora-Skrabaka M, Walkiewicz KW, Nowakowska-Zajdel E, Waniczek D, Strzelczyk JK. ADAM10 and ADAM17 as biomarkers linked to inflammation, metabolic disorders and colorectal cancer. Curr Issues Mol Biol. 2022;44(10):4517\u201327.","journal-title":"Curr Issues Mol Biol"},{"key":"3782_CR132","doi-asserted-by":"publisher","first-page":"581692","DOI":"10.3389\/fcell.2020.581692","volume":"8","author":"L Sun","year":"2020","unstructured":"Sun L, Chen B, Wu J, Jiang C, Fan Z, Feng Y, et al. Epigenetic regulation of a Disintegrin and metalloproteinase (ADAM) transcription in colorectal cancer cells: Involvement of \u03b2-catenin, BRG1, and KDM4. Front Cell Develop Biol. 2020;8:581692.","journal-title":"Front Cell Develop Biol"},{"issue":"1","key":"3782_CR133","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3892\/mmr.2014.2652","volume":"11","author":"S Liu","year":"2015","unstructured":"Liu S, Zhang W, Liu K, Ji B, Wang G. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells. Mol Med Rep. 2015;11(1):597\u2013602.","journal-title":"Mol Med Rep"},{"issue":"1","key":"3782_CR134","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3892\/ol.2020.11619","volume":"20","author":"Q Duan","year":"2020","unstructured":"Duan Q, Cai L, Zheng K, Cui C, Huang R, Zheng Z, et al. lncRNA KCNQ1OT1 knockdown inhibits colorectal cancer cell proliferation, migration and invasiveness via thePI3K\/AKT pathway. Oncol Lett. 2020;20(1):601\u201310.","journal-title":"Oncol Lett"},{"issue":"3","key":"3782_CR135","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41417-020-00211-6","volume":"28","author":"Y Li","year":"2021","unstructured":"Li Y, Shi B, Dong F, Zhu X, Liu B, Liu Y. LncRNA KCNQ1OT1 facilitates the progression of bladder cancer by targeting MiR-218-5p\/HS3ST3B1. Cancer Gene Ther. 2021;28(3):212\u201320.","journal-title":"Cancer Gene Ther"},{"issue":"10","key":"3782_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/atm-21-1761","volume":"9","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Shen Y, Chen R, Li H, Wu Y, Zhang F, et al. KCNQ1OT1 lncRNA affects the proliferation, apoptosis, and chemoresistance of small cell lung cancer cells via the JAK2\/STAT3 axis. Ann Transl Med. 2021;9(10):1.","journal-title":"Ann Transl Med"},{"key":"3782_CR137","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2147\/OTT.S288785","volume":"2021","author":"H Hao","year":"2021","unstructured":"Hao H, Chen H, Xie L, Liu H, Wang D. LncRNA KCNQ1OT1 promotes proliferation, invasion and metastasis of prostate cancer by regulating miR-211-5p\/CHI3L1 pathway. Onco Targets Ther. 2021;2021:1659\u201371.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"3782_CR138","first-page":"1","volume":"24","author":"C-Y Qiao","year":"2020","unstructured":"Qiao C-Y, Qiao T-Y, Jin H, Liu L-L, Zheng M-D, Wang Z-L. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1\/miR-124-3p\/TRIM14 axis. Eur Rev Med Pharmacol Sci. 2020;24(1):1.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"3782_CR139","doi-asserted-by":"publisher","first-page":"191","DOI":"10.14715\/cmb\/2020.66.3.31","volume":"66","author":"W Zhong","year":"2020","unstructured":"Zhong W, Dai Q, Huang Q. Effect of lncRNA KCNQ1OT1 on autophagy and drug resistance of hepatocellular carcinoma cells by targeting miR-338-3p. Cell Mol Biol (Noisy-le-grand). 2020;66(3):191\u20136.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"3782_CR140","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1007\/s11010-020-03856-x","volume":"476","author":"Z-h Zheng","year":"2021","unstructured":"Zheng Z-h, You H-y, Feng Y-j, Zhang Z-t. LncRNA KCNQ1OT1 is a key factor in the reversal effect of curcumin on cisplatin resistance in the colorectal cancer cells. Mol Cell Biochem. 2021;476:2575\u201385.","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"3782_CR141","first-page":"1255","volume":"46","author":"J Yuan","year":"2020","unstructured":"Yuan J, Lan H, Jiang X, Zeng D, Xiao S. Bcl-2 family: novel insight into individualized therapy for ovarian cancer. Int J Mol Med. 2020;46(4):1255\u201365.","journal-title":"Int J Mol Med"},{"issue":"1","key":"3782_CR142","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.1080\/21655979.2021.1958558","volume":"12","author":"F Lai","year":"2021","unstructured":"Lai F, Zhang H, Xu B, Xie Y, Yu H. Long non-coding RNA NBR2 suppresses the progress of colorectal cancer in vitro and in vivo by regulating the polarization of TAM. Bioengineered. 2021;12(1):5462\u201375.","journal-title":"Bioengineered"},{"key":"3782_CR143","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3389\/fonc.2020.00956","volume":"10","author":"W Yang","year":"2020","unstructured":"Yang W, Zheng Z, Yi P, Wang S, Zhang N, Ming J, et al. LncRNA NBR2 inhibits the malignancy of thyroid cancer, associated with enhancing the AMPK signaling. Front Oncol. 2020;10:956.","journal-title":"Front Oncol"},{"key":"3782_CR144","doi-asserted-by":"publisher","first-page":"111023","DOI":"10.1016\/j.biopha.2020.111023","volume":"133","author":"J-Q Sheng","year":"2021","unstructured":"Sheng J-Q, Wang M-R, Fang D, Liu L, Huang W-J, Tian D-A, et al. LncRNA NBR2 inhibits tumorigenesis by regulating autophagy in hepatocellular carcinoma. Biomed Pharmacother. 2021;133:111023.","journal-title":"Biomed Pharmacother"},{"issue":"24","key":"3782_CR145","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1080\/15384101.2016.1249545","volume":"15","author":"X Liu","year":"2016","unstructured":"Liu X, Gan B. lncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1. Cell Cycle. 2016;15(24):3471\u201381.","journal-title":"Cell Cycle"},{"key":"3782_CR146","doi-asserted-by":"publisher","first-page":"153303381987078","DOI":"10.1177\/1533033819870781","volume":"18","author":"H Yu","year":"2019","unstructured":"Yu H, Xie Y, Zhou Z, Wu Z, Dai X, Xu B. Curcumin regulates the progression of colorectal cancer via LncRNA NBR2\/AMPK pathway. Technol Cancer Res Treat. 2019;18:1533033819870781.","journal-title":"Technol Cancer Res Treat"},{"key":"3782_CR147","doi-asserted-by":"publisher","first-page":"216657","DOI":"10.1016\/j.canlet.2024.216657","volume":"2024","author":"G Zhao","year":"2024","unstructured":"Zhao G, Forn-Cun\u00ed G, Scheers M, Lindenbergh PP, Yin J, van Loosen Q, et al. Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer. Cancer Lett. 2024;2024:216657.","journal-title":"Cancer Lett"},{"issue":"2","key":"3782_CR148","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.18632\/aging.205460","volume":"16","author":"Y-R Tan","year":"2024","unstructured":"Tan Y-R, Jiang B-H, Feng W-J, He Z-L, Jiang Y-L, Xun Y, et al. Circ0060467 sponges miR-6805 to promote hepatocellular carcinoma progression through regulating AIFM2 and GPX4 expression. Aging (Albany). 2024;16(2):1796.","journal-title":"Aging (Albany)"},{"issue":"3","key":"3782_CR149","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/10799893.2021.1936554","volume":"42","author":"Q Chen","year":"2022","unstructured":"Chen Q, Guo H, Zong Y, Zhao X. Curcumin restrains hepatocellular carcinoma progression depending on the regulation of the circ_0078710\/miR-378b\/PRIM2 axis. J Recept Signal Transduct. 2022;42(3):313\u201324.","journal-title":"J Recept Signal Transduct"},{"issue":"1","key":"3782_CR150","doi-asserted-by":"publisher","first-page":"10993","DOI":"10.1038\/ncomms10993","volume":"7","author":"J Hyun","year":"2016","unstructured":"Hyun J, Wang S, Kim J, Rao KM, Park SY, Chung I, et al. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Nat Commun. 2016;7(1):10993.","journal-title":"Nat Commun"},{"issue":"2","key":"3782_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbc.2021.100996","volume":"297","author":"H Liu","year":"2021","unstructured":"Liu H, Lu Z, Shi X, Liu L, Zhang P, Golemis EA, et al. HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression. J Biol Chem. 2021;297(2):1.","journal-title":"J Biol Chem"},{"key":"3782_CR152","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.biopha.2018.08.030","volume":"107","author":"L-H Jiang","year":"2018","unstructured":"Jiang L-H, Hou J-C, Zhong S-L, Zhou S-Y, Zhu L-P, Li J, et al. Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer. Biomed Pharmacother. 2018;107:1342\u201353.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"3782_CR153","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1111\/jgh.15545","volume":"36","author":"J Zhao","year":"2021","unstructured":"Zhao J, Nie W, Dong L, Liu W, Wei W. A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2\/STAT3 signaling pathway via the circular RNA zinc finger protein 83\/microRNA-324-5p\/cyclin-dependent kinase 16 axis. J Gastroenterol Hepatol. 2021;36(10):2967\u201377.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"3782_CR154","first-page":"2451","volume":"17","author":"D Xiu","year":"2019","unstructured":"Xiu D, Wang D, Wang J, Ji F, Zhang W. MicroRNA-543 suppresses liver cancer growth and induces apoptosis via the JAK2\/STAT3 signaling pathway. Oncol Lett. 2019;17(2):2451\u20136.","journal-title":"Oncol Lett"},{"key":"3782_CR155","first-page":"12","volume":"2021","author":"X Hu","year":"2021","unstructured":"Hu X, Jiao F, Zhang L, Jiang Y. Dihydrotanshinone inhibits hepatocellular carcinoma by suppressing the JAK2\/STAT3 pathway. Front Pharmacol. 2021;2021:12.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3782_CR156","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1515\/biol-2021-0092","volume":"16","author":"S Li","year":"2021","unstructured":"Li S, Zhang L, Li S, Zhao H, Chen Y. Curcumin suppresses the progression of gastric cancer by regulating circ_0056618\/miR-194-5p axis. Open Life Sci. 2021;16(1):937\u201349.","journal-title":"Open Life Sci"},{"issue":"7078","key":"3782_CR157","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nature04431","volume":"439","author":"E Vir\u00e9","year":"2006","unstructured":"Vir\u00e9 E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, et al. The polycomb group protein EZH2 directly controls DNA methylation. Nature. 2006;439(7078):871\u20134.","journal-title":"Nature"},{"issue":"1","key":"3782_CR158","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ijc.30414","volume":"140","author":"CH Li","year":"2017","unstructured":"Li CH, Xiao Z, Tong JHM, To KF, Fang X, Cheng AS, et al. EZH 2 coupled with HOTAIR to silence Micro RNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma. Int J Cancer. 2017;140(1):120\u20139.","journal-title":"Int J Cancer"},{"issue":"21","key":"3782_CR159","doi-asserted-by":"publisher","first-page":"5305","DOI":"10.3390\/cancers13215305","volume":"13","author":"P Chaudhary","year":"2021","unstructured":"Chaudhary P, Guragain D, Chang J-H, Kim J-A. TPH1 and 5-HT7 receptor overexpression leading to gemcitabine-resistance requires non-canonical permissive action of EZH2 in pancreatic ductal adenocarcinoma. Cancers. 2021;13(21):5305.","journal-title":"Cancers"},{"issue":"10","key":"3782_CR160","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41419-021-04118-4","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y, Ren D, Zhou Y, Shen J, Wu H, Jin X. Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1\/EZH2 complex in pancreatic cancer. Cell Death Dis. 2021;12(10):878.","journal-title":"Cell Death Dis"},{"key":"3782_CR161","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1007\/s00018-019-03222-1","volume":"76","author":"K Jin","year":"2019","unstructured":"Jin K, Wang S, Zhang Y, Xia M, Mo Y, Li X, et al. Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis. Cell Mol Life Sci. 2019;76:4275\u201389.","journal-title":"Cell Mol Life Sci"},{"issue":"20","key":"3782_CR162","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1158\/1078-0432.CCR-12-0977","volume":"18","author":"DM Miller","year":"2012","unstructured":"Miller DM, Thomas SD, Islam A, Muench D, Sedoris K. c-Myc and cancer metabolism. Clin Cancer Res. 2012;18(20):5546\u201353.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"3782_CR163","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/carcin\/bgx065","volume":"38","author":"K Yoshida","year":"2017","unstructured":"Yoshida K, Toden S, Ravindranathan P, Han H, Goel A. Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression. Carcinogenesis. 2017;38(10):1036\u201346.","journal-title":"Carcinogenesis"},{"key":"3782_CR164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-021-00916-8","volume":"14","author":"S Sun","year":"2021","unstructured":"Sun S, Fang H. Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3\/miR-320a\/SMG1 axis. J Ovarian Res. 2021;14:1\u201313.","journal-title":"J Ovarian Res"},{"key":"3782_CR165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1080-5","volume":"18","author":"L Zhang","year":"2019","unstructured":"Zhang L, Zhou Q, Qiu Q, Hou L, Wu M, Li J, et al. CircPLEKHM3 acts as a tumor suppressor through regulation of the miR-9\/BRCA1\/DNAJB6\/KLF4\/AKT1 axis in ovarian cancer. Mol Cancer. 2019;18:1\u201319.","journal-title":"Mol Cancer"},{"issue":"5","key":"3782_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2020.9137","volume":"20","author":"L Kong","year":"2020","unstructured":"Kong L, Sun Y, Chen M, Dai Y, Liu Z. Downregulation of microRNA-320a inhibits proliferation and induces apoptosis of retinoblastoma cells via targeting TUSC3. Exp Ther Med. 2020;20(5):1.","journal-title":"Exp Ther Med"},{"key":"3782_CR167","doi-asserted-by":"publisher","first-page":"8833","DOI":"10.2147\/CMAR.S244123","volume":"2020","author":"X Ma","year":"2020","unstructured":"Ma X, Wang Z, Ren H, Bao X, Zhang Y, Wang B, et al. Long non-coding RNA GAS5 suppresses tumor progression and enhances the radiosensitivity of prostate cancer through the miR-320a\/RAB21 axis. Cancer Manag Res. 2020;2020:8833\u201345.","journal-title":"Cancer Manag Res"},{"key":"3782_CR168","doi-asserted-by":"publisher","first-page":"581932","DOI":"10.3389\/fonc.2021.581932","volume":"11","author":"L Zhang","year":"2021","unstructured":"Zhang L, Chen H, He F, Zhang S, Li A, Zhang A, et al. MicroRNA-320a promotes epithelial ovarian cancer cell proliferation and invasion by targeting RASSF8. Front Oncol. 2021;11:581932.","journal-title":"Front Oncol"},{"issue":"9","key":"3782_CR169","doi-asserted-by":"publisher","first-page":"17065","DOI":"10.3390\/ijms150917065","volume":"15","author":"Y Du","year":"2014","unstructured":"Du Y, Lu F, Li P, Ye J, Ji M, Ma D, et al. SMG1 acts as a novel potential tumor suppressor with epigenetic inactivation in acute myeloid leukemia. Int J Mol Sci. 2014;15(9):17065\u201376.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3782_CR170","doi-asserted-by":"publisher","first-page":"18825","DOI":"10.1002\/jcp.28521","volume":"234","author":"Z Yin","year":"2019","unstructured":"Yin Z, Ma T, Yan J, Shi N, Zhang C, Lu X, et al. LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p\/SMG1 signaling pathway. J Cell Physiol. 2019;234(10):18825\u201336.","journal-title":"J Cell Physiol"},{"issue":"1","key":"3782_CR171","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3892\/ol.2020.11624","volume":"20","author":"S Zeng","year":"2020","unstructured":"Zeng S, Liu S, Feng J, Gao J, Xue F. MicroRNA-32 promotes ovarian cancer cell proliferation and motility by targeting SMG1. Oncol Lett. 2020;20(1):733\u201341.","journal-title":"Oncol Lett"},{"issue":"1","key":"3782_CR172","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/cam4.1237","volume":"7","author":"X Zhang","year":"2018","unstructured":"Zhang X, Peng Y, Huang Y, Yang M, Yan R, Zhao Y, et al. SMG-1 inhibition by miR-192\/-215 causes epithelial-mesenchymal transition in gastric carcinogenesis via activation of Wnt signaling. Cancer Med. 2018;7(1):146\u201356.","journal-title":"Cancer Med"},{"issue":"11","key":"3782_CR173","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41419-019-2060-9","volume":"10","author":"S Mai","year":"2019","unstructured":"Mai S, Xiao R, Shi L, Zhou X, Yang T, Zhang M, et al. MicroRNA-18a promotes cancer progression through SMG1 suppression and mTOR pathway activation in nasopharyngeal carcinoma. Cell Death Dis. 2019;10(11):819.","journal-title":"Cell Death Dis"},{"key":"3782_CR174","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s00404-019-05058-3","volume":"299","author":"L-D Liu","year":"2019","unstructured":"Liu L-D, Pang Y-X, Zhao X-R, Li R, Jin C-J, Xue J, et al. Curcumin induces apoptotic cell death and protective autophagy by inhibiting AKT\/mTOR\/p70S6K pathway in human ovarian cancer cells. Arch Gynecol Obstet. 2019;299:1627\u201339.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"3782_CR175","doi-asserted-by":"publisher","first-page":"17267","DOI":"10.1038\/s41598-019-53509-3","volume":"9","author":"H-Y Yen","year":"2019","unstructured":"Yen H-Y, Tsao C-W, Lin Y-W, Kuo C-C, Tsao C-H, Liu C-Y. Regulation of carcinogenesis and modulation through Wnt\/\u03b2-catenin signaling by curcumin in an ovarian cancer cell line. Sci Rep. 2019;9(1):17267.","journal-title":"Sci Rep"},{"key":"3782_CR176","doi-asserted-by":"publisher","first-page":"105751","DOI":"10.1016\/j.biocel.2020.105751","volume":"123","author":"W Liang","year":"2020","unstructured":"Liang W, Xia B, He C, Zhai G, Li M, Zhou J. Overexpression of LINC00691 promotes the proliferation and invasion of gastric cancer cells via the Janus kinase\/signal transducer and activator of transcription signalling pathway. Int J Biochem Cell Biol. 2020;123:105751.","journal-title":"Int J Biochem Cell Biol"},{"issue":"8","key":"3782_CR177","doi-asserted-by":"publisher","first-page":"e23357","DOI":"10.1002\/jcla.23357","volume":"34","author":"Y Xie","year":"2020","unstructured":"Xie Y, Hu X. Increased levels of long noncoding RNA LINC00691 correlate with poor prognosis in non\u2013small-cell lung cancer patients. J Clin Lab Anal. 2020;34(8):e23357.","journal-title":"J Clin Lab Anal"},{"key":"3782_CR178","first-page":"1","volume":"2022","author":"Z Li","year":"2022","unstructured":"Li Z, Gao Y, Li L, Xie S. Curcumin inhibits papillary thyroid cancer cell proliferation by regulating lncRNA LINC00691. Anal Cell Pathol. 2022;2022:1.","journal-title":"Anal Cell Pathol"},{"issue":"3","key":"3782_CR179","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW. The Warburg effect: How does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211\u20138.","journal-title":"Trends Biochem Sci"},{"issue":"7","key":"3782_CR180","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","volume":"95","author":"P Vaupel","year":"2019","unstructured":"Vaupel P, Schmidberger H, Mayer A. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 2019;95(7):912\u20139.","journal-title":"Int J Radiat Biol"},{"key":"3782_CR181","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9515071","volume":"2020","author":"X Tang","year":"2020","unstructured":"Tang X, Zhang W, Ye Y, Li H, Cheng L, Zhang M, et al. LncRNA HOTAIR contributes to sorafenib resistance through suppressing miR-217 in hepatic carcinoma. BioMed Res Int. 2020;2020:1.","journal-title":"BioMed Res Int"},{"issue":"1","key":"3782_CR182","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12967-020-02320-0","volume":"18","author":"H Mozdarani","year":"2020","unstructured":"Mozdarani H, Ezzatizadeh V, Rahbar PR. The emerging role of the long non-coding RNA HOTAIR in breast cancer development and treatment. J Transl Med. 2020;18(1):152.","journal-title":"J Transl Med"},{"key":"3782_CR183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-018-1153-4","volume":"13","author":"N Li","year":"2018","unstructured":"Li N, Meng D-D, Gao L, Xu Y, Liu P-J, Tian Y-W, et al. Overexpression of HOTAIR leads to radioresistance of human cervical cancer via promoting HIF-1\u03b1 expression. Radiat Oncol. 2018;13:1\u20139.","journal-title":"Radiat Oncol"},{"issue":"6","key":"3782_CR184","first-page":"7223","volume":"8","author":"S Hao","year":"2015","unstructured":"Hao S, Shao Z. HOTAIR is upregulated in acute myeloid leukemia and that indicates a poor prognosis. Int J Clin Exp Pathol. 2015;8(6):7223.","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"3782_CR185","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/s41374-021-00640-3","volume":"101","author":"J-M Liu","year":"2021","unstructured":"Liu J-M, Li M, Luo W, Sun H-B. Curcumin attenuates Adriamycin-resistance of acute myeloid leukemia by inhibiting the lncRNA HOTAIR\/miR-20a-5p\/WT1 axis. Lab Invest. 2021;101(10):1308\u201317.","journal-title":"Lab Invest"},{"issue":"3","key":"3782_CR186","first-page":"2426","volume":"20","author":"H Liu","year":"2019","unstructured":"Liu H, Wang X, Zhang H, Wang J, Chen Y, Ma T, et al. Dynamic changes in the level of WT1 as an MRD marker to predict the therapeutic outcome of patients with AML with and without allogeneic stem cell transplantation. Mol Med Rep. 2019;20(3):2426\u201332.","journal-title":"Mol Med Rep"},{"issue":"13","key":"3782_CR187","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.3390\/cancers15133491","volume":"15","author":"N Niktoreh","year":"2023","unstructured":"Niktoreh N, Weber L, Walter C, Karimifard M, Hoffmeister LM, Breiter H, et al. Understanding WT1 alterations and expression profiles in hematological malignancies. Cancers. 2023;15(13):3491.","journal-title":"Cancers"},{"issue":"2","key":"3782_CR188","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/onc.2008.373","volume":"28","author":"M Mourtada-Maarabouni","year":"2009","unstructured":"Mourtada-Maarabouni M, Pickard M, Hedge V, Farzaneh F, Williams G. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene. 2009;28(2):195\u2013208.","journal-title":"Oncogene"},{"issue":"1\u20133","key":"3782_CR189","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejphar.2012.06.016","volume":"689","author":"AM Alizadeh","year":"2012","unstructured":"Alizadeh AM, Khaniki M, Azizian S, Mohaghgheghi MA, Sadeghizadeh M, Najafi F. Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier\u2013curcumin. Eur J Pharmacol. 2012;689(1\u20133):226\u201332.","journal-title":"Eur J Pharmacol"},{"key":"3782_CR190","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.phymed.2018.03.022","volume":"42","author":"MJD Esmatabadi","year":"2018","unstructured":"Esmatabadi MJD, Motamedrad M, Sadeghizadeh M. Down-regulation of lncRNA, GAS5 decreases chemotherapeutic effect of dendrosomal curcumin (DNC) in breast cancer cells. Phytomedicine. 2018;42:56\u201365.","journal-title":"Phytomedicine"},{"issue":"1","key":"3782_CR191","doi-asserted-by":"publisher","first-page":"e2569","DOI":"10.1038\/cddis.2016.438","volume":"8","author":"F Peng","year":"2018","unstructured":"Peng F, Li T-T, Wang K-L, Xiao G-Q, Wang J-H, Zhao H-D, et al. H19\/let-7\/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance. Cell Death Dis. 2018;8(1):e2569.","journal-title":"Cell Death Dis"},{"issue":"54","key":"3782_CR192","doi-asserted-by":"publisher","first-page":"91990","DOI":"10.18632\/oncotarget.21121","volume":"8","author":"Q-N Zhu","year":"2017","unstructured":"Zhu Q-N, Wang G, Guo Y, Peng Y, Zhang R, Deng J-L, et al. LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway. Oncotarget. 2017;8(54):91990.","journal-title":"Oncotarget"},{"issue":"3","key":"3782_CR193","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.bbamcr.2012.12.002","volume":"1833","author":"G-M Jiang","year":"2013","unstructured":"Jiang G-M, Wang H-S, Zhang F, Zhang K-S, Liu Z-C, Fang R, et al. Histone deacetylase inhibitor induction of epithelial\u2013mesenchymal transitions via up-regulation of Snail facilitates cancer progression. Biochim Biophys Acta (BBA) Mol Cell Res. 2013;1833(3):663\u201371.","journal-title":"Biochim Biophys Acta (BBA) Mol Cell Res"},{"issue":"1\u20133","key":"3782_CR194","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000101320","volume":"185","author":"MI Kokkinos","year":"2007","unstructured":"Kokkinos MI, Wafai R, Wong MK, Newgreen DF, Thompson EW, Waltham M. Vimentin and epithelial-mesenchymal transition in human breast cancer\u2013observations in vitro and in vivo. Cells Tissues Organs. 2007;185(1\u20133):191\u2013203.","journal-title":"Cells Tissues Organs"},{"issue":"2","key":"3782_CR195","first-page":"204","volume":"45","author":"A Stepan","year":"2019","unstructured":"Stepan A, Margaritescu C, Simionescu C, Ciurea R. E-cadherin and snail immunoexpression in colorectal adenocarcinomas. Curr Health Sci J. 2019;45(2):204.","journal-title":"Curr Health Sci J"},{"issue":"1","key":"3782_CR196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2020.11651","volume":"23","author":"J Cai","year":"2021","unstructured":"Cai J, Sun H, Zheng B, Xie M, Xu C, Zhang G, et al. Curcumin attenuates lncRNA H19-induced epithelial-mesenchymal transition in tamoxifen-resistant breast cancer cells. Mol Med Rep. 2021;23(1):1.","journal-title":"Mol Med Rep"},{"key":"3782_CR197","doi-asserted-by":"publisher","first-page":"153218","DOI":"10.1016\/j.phymed.2020.153218","volume":"70","author":"T Saghatelyan","year":"2020","unstructured":"Saghatelyan T, Tananyan A, Janoyan N, Tadevosyan A, Petrosyan H, Hovhannisyan A, et al. Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: a comparative, randomized, double-blind, placebo-controlled clinical trial. Phytomedicine. 2020;70:153218.","journal-title":"Phytomedicine"},{"issue":"6","key":"3782_CR198","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/pros.23766","volume":"79","author":"YH Choi","year":"2019","unstructured":"Choi YH, Han DH, Kim S, Kim MJ, Sung HH, Jeon HG, et al. A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation. Prostate. 2019;79(6):614\u201321.","journal-title":"Prostate"},{"issue":"7","key":"3782_CR199","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/jn\/nxz029","volume":"149","author":"LM Howells","year":"2019","unstructured":"Howells LM, Iwuji CO, Irving GR, Barber S, Walter H, Sidat Z, et al. Curcumin combined with FOLFOX chemotherapy is safe and tolerable in patients with metastatic colorectal cancer in a randomized phase IIa trial. J Nutr. 2019;149(7):1133\u20139.","journal-title":"J Nutr"},{"key":"3782_CR200","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.phrs.2018.03.013","volume":"132","author":"D Pastorelli","year":"2018","unstructured":"Pastorelli D, Fabricio AS, Giovanis P, D\u2019Ippolito S, Fiduccia P, Sold\u00e0 C, et al. Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial. Pharmacol Res. 2018;132:72\u20139.","journal-title":"Pharmacol Res"},{"key":"3782_CR201","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fnut.2018.00138","volume":"5","author":"S Tuyaerts","year":"2019","unstructured":"Tuyaerts S, Rombauts K, Everaert T, Van Nuffel AM, Amant F. A phase 2 study to assess the immunomodulatory capacity of a lecithin-based delivery system of curcumin in endometrial cancer. Front Nutr. 2019;5:138.","journal-title":"Front Nutr"},{"issue":"8","key":"3782_CR202","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/cncr.32644","volume":"126","author":"SK Basak","year":"2020","unstructured":"Basak SK, Bera A, Yoon AJ, Morselli M, Jeong C, Tosevska A, et al. A randomized, phase 1, placebo-controlled trial of APG-157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor-associated microbes. Cancer. 2020;126(8):1668\u201382.","journal-title":"Cancer"},{"issue":"11","key":"3782_CR203","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1182\/blood.V110.11.1177.1177","volume":"110","author":"S Vadhan-Raj","year":"2007","unstructured":"Vadhan-Raj S, Weber DM, Wang M, Giralt SA, Thomas SK, Alexanian R, et al. Curcumin downregulates NF-kB and related genes in patients with multiple myeloma: results of a phase I\/II study. Blood. 2007;110(11):1177.","journal-title":"Blood"},{"issue":"6","key":"3782_CR204","first-page":"443","volume":"14","author":"B Lal","year":"2000","unstructured":"Lal B, Kapoor A, Agrawal P, Asthana O, Srimal R. Role of curcumin in idiopathic inflammatory orbital pseudotumours. Phytother Res Int J Dev Pharmacol Toxicol Eval Nat Prod Derivat. 2000;14(6):443\u20137.","journal-title":"Phytother Res Int J Dev Pharmacol Toxicol Eval Nat Prod Derivat"},{"issue":"18","key":"3782_CR205","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.1158\/1078-0432.CCR-11-1272","volume":"17","author":"SG Kim","year":"2011","unstructured":"Kim SG, Veena MS, Basak SK, Han E, Tajima T, Gjertson DW, et al. Curcumin treatment suppresses IKK\u03b2 kinase activity of salivary cells of patients with head and neck cancer: a pilot study. Clin Cancer Res. 2011;17(18):5953\u201361.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3782_CR206","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4161\/cbt.9.1.10392","volume":"9","author":"M Bayet-Robert","year":"2010","unstructured":"Bayet-Robert M, Kwiatowski F, Leheurteur M, Gachon F, Planchat E, Abrial C, et al. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol Ther. 2010;9(1):8\u201314.","journal-title":"Cancer Biol Ther"},{"issue":"10","key":"3782_CR207","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/pros.21147","volume":"70","author":"H Ide","year":"2010","unstructured":"Ide H, Tokiwa S, Sakamaki K, Nishio K, Isotani S, Muto S, et al. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. Prostate. 2010;70(10):1127\u201333.","journal-title":"Prostate"},{"issue":"14","key":"3782_CR208","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-08-0024","volume":"14","author":"N Dhillon","year":"2008","unstructured":"Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008;14(14):4491\u20139.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"3782_CR209","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1080\/01635581.2010.513802","volume":"62","author":"R Epelbaum","year":"2010","unstructured":"Epelbaum R, Schaffer M, Vizel B, Badmaev V, Bar-Sela G. Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr Cancer. 2010;62(8):1137\u201341.","journal-title":"Nutr Cancer"},{"key":"3782_CR210","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00280-010-1470-2","volume":"68","author":"M Kanai","year":"2011","unstructured":"Kanai M, Yoshimura K, Asada M, Imaizumi A, Suzuki C, Matsumoto S, et al. A phase I\/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol. 2011;68:157\u201364.","journal-title":"Cancer Chemother Pharmacol"},{"key":"3782_CR211","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00280-013-2151-8","volume":"71","author":"M Kanai","year":"2013","unstructured":"Kanai M, Otsuka Y, Otsuka K, Sato M, Nishimura T, Mori Y, et al. A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin\u00ae) in cancer patients. Cancer Chemother Pharmacol. 2013;71:1521\u201330.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7","key":"3782_CR212","first-page":"1894","volume":"7","author":"RA Sharma","year":"2001","unstructured":"Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res. 2001;7(7):1894\u2013900.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3782_CR213","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3109\/07357907.2010.550592","volume":"29","author":"Z-Y He","year":"2011","unstructured":"He Z-Y, Shi C-B, Wen H, Li F-L, Wang B-L, Wang J. Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Invest. 2011;29(3):208\u201313.","journal-title":"Cancer Invest"},{"issue":"2","key":"3782_CR214","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ptr.6230","volume":"33","author":"A Saadipoor","year":"2019","unstructured":"Saadipoor A, Razzaghdoust A, Simforoosh N, Mahdavi A, Bakhshandeh M, Moghadam M, et al. Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy. Phytother Res. 2019;33(2):370\u20138.","journal-title":"Phytother Res"},{"issue":"7","key":"3782_CR215","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1002\/cam4.3806","volume":"10","author":"J Passildas-Jahanmohan","year":"2021","unstructured":"Passildas-Jahanmohan J, Eymard JC, Pouget M, Kwiatkowski F, Van Praagh I, Savareux L, et al. Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first-line treatment of metastatic castration-resistant prostate cancer. Cancer Med. 2021;10(7):2332\u201340.","journal-title":"Cancer Med"},{"issue":"21","key":"3782_CR216","doi-asserted-by":"publisher","first-page":"11596","DOI":"10.3390\/ijms222111596","volume":"22","author":"M Hueso","year":"2021","unstructured":"Hueso M, Mall\u00e9n A, Su\u00f1\u00e9-Pou M, Aran JM, Su\u00f1\u00e9-Negre JM, Navarro E. ncRNAs in therapeutics: challenges and limitations in nucleic acid-based drug delivery. Int J Mol Sci. 2021;22(21):11596.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3782_CR217","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics\u2014challenges and potential solutions. Nat Rev Drug Disc. 2021;20(8):629\u201351.","journal-title":"Nat Rev Drug Disc"},{"key":"3782_CR218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-019-0045-y","volume":"21","author":"DB Fathi","year":"2020","unstructured":"Fathi DB. Strategies to target long non-coding RNAs in cancer treatment: progress and challenges. Egypt J Med Hum Genet. 2020;21:1\u201315.","journal-title":"Egypt J Med Hum Genet"},{"key":"3782_CR219","first-page":"1","volume":"2024","author":"A Goel","year":"2024","unstructured":"Goel A, Rastogi A, Jain M, Niveriya K. RNA-based therapeutics: past, present and future prospects, challenges in cancer treatment. Curr Pharm Biotechnol. 2024;2024:1.","journal-title":"Curr Pharm Biotechnol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03782-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03782-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03782-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T15:04:51Z","timestamp":1747407891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03782-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":219,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["3782"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03782-0","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}